32. Chronic lymphocytic leukemia patients who develop resistance to Bruton Tyrosine Kinase (BTK) inhibitors demonstrate heterogeneous patterns of clonal evolution
Kanagal-Shamanna, Rashmi, Jain, Preetesh, Patel, Keyur, Bueso-Ramos, Carlos, Luthra, Rajyalakshmi, Routbort, Mark, Estrov, Zeev, Wierda, William, Medeiros, L. JeffreyVolume:
226-227
Language:
english
Journal:
Cancer Genetics
DOI:
10.1016/j.cancergen.2018.04.093
Date:
October, 2018
File:
PDF, 47 KB
english, 2018